Search results for " pharmaceutical" in Articles / App Notes
Article
From Darwin to Recombinant Fc Multimers
Carlos Bosques from Momenta Pharmaceuticals had a presentation titled IVIg-Inspired Drugs for Improved Therapy in Autoimmune Diseases in the Application session. IVIg has been a treatment optio…
Article
Managing Residual Impurities During Downstream Processing
…ufacture of biologic drugs, according to Ashleigh Wake, director of biological services for Intertek Pharmaceutical Services.
The scientific and technical fields are evolving, agrees Bérangère Tis…
Article
Witnessing Major Growth in Next-Generation Antibodies
Both large and small pharmaceutical and biotech companies are pursuing these newer therapies. A few have already been approved, and many more are in preclinical and clinical development. There are num…
Article
Cost Considerations Drive Lean Technology in Biopharmaceutical Manufacturing
The problem of copying biologics
Biologic drugs have revolutionized the pharmaceutical industry by attacking disease using the mechanisms of the cell and immune system. These therapies are fragile…
Article
Advancing Single-Use Technology Through Collaboration
“In the traditional pharmaceutical business, you spend a lot of time washing and sterilizing items to avoid the cross-contamination concerns. In single use, that water use is reduced to almost nothing…
Article
Lessons Learned Accelerate Vaccine Development
Teamwork and multi-tasking at Janssen
Janssen Vaccines, part of the Janssen Pharmaceutical Companies of Johnson & Johnson, received the 2016 Facility of the Year Award for Project Execution for it…
Article
Innovative Therapies Require Modern Manufacturing Systems
Jenkins voiced concern, however, about the continued emergence of new therapies, noting the need for FDA to assist pharmaceutical manufacturers seeking to accelerate the production timeframes for more…
Article
Risk Assessment and Mitigation in Biopharmaceutical Manufacturing
In general, a biopharmaceutical manufacturer faces similar business continuity risks as those of traditional pharmaceutical manufacturers.
BioPharm: Does the use of single-use systems (SUS) and/or…
Article
USP Stresses Pharmacopeial Standards at CPhI China
Keynote speakers included former FDA officials, USP experts, members of the Chinese Pharmacopoeia Commission, and senior pharmaceutical executives.
The seminar was designed to explain the latest q…
Article
Biopharma Advances Demand Specialized Expertise
…al development/manufacturing processes?
McNally (PPD Consulting): FDA established a new Office of Pharmaceutical Quality in 2014, which we anticipate will have major impacts on the biopharmaceutic…